Patients with colon cancer who consumed an anti-inflammatory diet during a phase 3 clinical trial showed longer overall survival post-treatment compared to those on a proinflammatory diet, according ...

Exercise is generally good for you, but a new high-quality clinical trial finds that it’s so good, it can even knock back colon cancer—and, in fact, rival some chemotherapy treatments. The finding ...

A three-year exercise program improved survival in colon cancer patients and kept disease at bay, a first-of-its-kind international experiment showed. With the benefits rivaling some drugs, experts ...

Can exercise “therapy” and diet improve survival in patients with colon cancer? It appears so, according to two pivotal studies presented at American Society of Clinical Oncology (ASCO) 2025 annual ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

Patients with colon cancer who consumed an anti-inflammatory diet during a Phase III clinical trial showed longer overall survival post-treatment compared to those on a proinflammatory diet, according ...

Patients with metastatic colorectal cancer that had stopped responding to at least two prior treatment regimens gained meaningful extra months of life when bevacizumab was added to the chemotherapy ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new study published by The New England Journal of Medicine on Sunday ...

Don’t stall — your butt is on the line. Because of this worrisome trend, the US Preventive Services Task Force (USPSTF) lowered its recommendation for starting colorectal cancer screening from age 50 ...

Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...